Bristol-Myers Squibb Company
Status: Publicly traded
Direct answer
Bristol-Myers Squibb Company is publicly traded on NYSE under the ticker BMY.
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings...
Can you invest in Bristol-Myers Squibb Company?
Yes. Bristol-Myers Squibb Company is publicly traded on NYSE under the ticker BMY.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Bristol-Myers Squibb Company
Detailed equity research is provided by MarketSnap.